View Older Stories

Feb 23, 2026 12:32PM Morgan Stanley: 'Big picture this acquisition bolsters GILD's established position in CAR-T in oncology'

Feb 23, 2026 09:31AM Raymond James on Legend Biotech Corp. (LEGN): 'Arcellx Takeout Indicates Legend is Hugely Undervalued'

Feb 23, 2026 08:09AM Truist Securities Downgrades Arcellx Inc. (ACLX) to Hold

Feb 20, 2026 06:02AM Barclays Starts Gilead Sciences (GILD) at Equalweight

Feb 18, 2026 10:27AM Gilead Sciences (GILD) PT Raised to $175 at UBS

Feb 12, 2026 05:40AM Gilead Sciences (GILD) PT Raised to $170 at Wolfe Research

Feb 11, 2026 09:33AM Gilead Sciences (GILD) PT Raised to $152 at Truist Securities

Feb 11, 2026 09:27AM Gilead Sciences (GILD) PT Raised to $160 at Bernstein SocGen Group

Feb 11, 2026 08:36AM Gilead Sciences (GILD) PT Raised to $162 at BofA Securities

Feb 11, 2026 07:09AM Gilead Sciences (GILD) PT Raised to $170 at Needham

Feb 11, 2026 05:08AM Gilead Sciences (GILD) PT Raised to $160 at BMO Capital

Feb 11, 2026 05:04AM Goldman Sachs Reiterates Neutral Rating on Gilead Sciences (GILD)

Feb 11, 2026 04:27AM Stocks expected to have increasing option volume: GILD HOOD NET EW ZG Z LYFT FRSH MCD TMUS SHOP HLT KHC THC U BWA ULCC HUM THC BWA ULC

Feb 10, 2026 04:43PM After-hours movers: Robinhood, Ford, Lyft, Mattel, Cloudflare, Upstart

Feb 10, 2026 04:03PM Gilead Sciences (GILD) Tops Q4 EPS by 1c, Offers Guidance

Feb 10, 2026 04:02PM Gilead Sciences (GILD) Raises Quarterly Dividend 3.8% to $0.82; 2.2% Yield

Feb 9, 2026 11:01AM Gilead Sciences (GILD) call put ratio 1.2 calls to 1 put into quarter results

Feb 9, 2026 06:05AM Gilead Sciences (GILD) call put ratio 2.8 calls to 1 put into quarter results

Jan 30, 2026 06:28AM Gilead Sciences (GILD) PT Raised to $146 at Leerink Partners

Jan 29, 2026 09:46AM Truist Securities Reiterates Buy Rating on Gilead Sciences (GILD)

Jan 27, 2026 08:24AM Gilead Sciences (GILD) PT Raised to $145 at Truist Securities

Jan 26, 2026 09:35AM Gilead Sciences (GILD) PT Raised to $150 at BMO Capital

Jan 20, 2026 09:30AM Bernstein Reiterates Outperform Rating on Gilead Sciences (GILD)

Jan 15, 2026 09:35AM UBS Reiterates Buy Rating on Gilead Sciences (GILD)

Jan 13, 2026 08:28AM BMO Capital on Gilead Sciences (GILD): 'Yeztugo Launch Continues to Impress'

Jan 9, 2026 06:28AM Gilead Sciences (GILD) PT Raised to $154 at BofA Securities

Jan 8, 2026 11:25AM Gilead Sciences (GILD) call put ratio 1 call to 1.4 puts into the annual J.P. Morgan Healthcare Conference

Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC

Jan 7, 2026 03:03AM UBS Assumes Gilead Sciences (GILD) at Buy

Jan 6, 2026 07:04AM OncoNano partners with Gilead to test drug delivery technology

Dec 29, 2025 07:26AM Bernstein Reiterates Outperform Rating on Gilead Sciences (GILD)

Dec 24, 2025 07:00AM Gilead Sciences acquires Repare drug candidate for up to $30 million

Dec 22, 2025 08:02AM Gilead exercises option for Assembly Bio's herpes treatment programs

Dec 19, 2025 02:24PM 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts

Dec 19, 2025 02:21PM GILEAD reaches three-year pricing agreement with US government

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 15, 2025 05:55AM Gilead Sciences (GILD) PT Raised to $150 at Wolfe Research

Dec 12, 2025 08:34AM Gilead Sciences (GILD) discontinues Phase 3 STAR-221 study

Dec 8, 2025 02:53AM Kite reports 96% response rate in multiple myeloma trial

Dec 8, 2025 02:53AM Kite presents new Yescarta data showing consistent benefits across lymphoma patients

Nov 25, 2025 08:02AM BMO Capital Reiterates Outperform Rating on Gilead Sciences (GILD)

Nov 24, 2025 06:46AM Truist Securities Assumes Gilead Sciences (GILD) at Buy

Nov 21, 2025 06:34AM Gilead Sciences (GILD) PT Raised to $140 at Mizuho

Nov 19, 2025 08:33AM Gilead Sciences announces executive departure in December

Nov 18, 2025 05:09AM Gilead ships first lenacapavir doses to sub-Saharan Africa

Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers

Nov 12, 2025 04:03PM Scotiabank Starts Gilead Sciences (GILD) at Sector Outperform

Nov 10, 2025 11:09AM Gilead Sciences (GILD) CFO: HIV business is now projected to grow 5% this year - Conference Call

Nov 7, 2025 08:01AM GILD presents long-term data on Livdelzi for liver disease treatment

Nov 3, 2025 07:12AM Bernstein on Gilead Sciences (GILD): 'We Still Like This Story'

View Older Stories